4-(2'-羟基苯甲酰肼)苯亚甲基／亚乙基－5－甲基－2－苯基－2，4－二氢－吡唑啉酮－3超分子化合物的合成与晶体结构

报道了4-(2'－羟基苯甲酰肼)苯亚甲基－5－甲基－2－苯基－2，4－二氢－吡 唑啉酮－3（B_1）和4-(2'－羟基苯甲酰肼)亚乙基－5－甲基－2－苯基－2，4－二 氢－吡唑啉酮－3（B_2）的合成、表征及晶体结构分析，B_1晶体属单斜晶系， C2/c空间群，所得晶胞参数为：a = 1.4201(2) nm, b = 1.65542(2) nm, c = 1. 8455(3) nm, β = 101.32(1)°，V = 4.2541(10) nm~3, Z = 8, D_c = 1.344 g/cm~3, μ = 0.094 mm~(-1), F(000) = 1808, R = 0.0442, wR = 0.1037。该 化合物由水分子通过氢键连接成沿ac面无限延伸的二维网络结构的超分子。B_2晶 体属三斜晶系，P1空间群，a = 1.2120(2) nm, b = 1.2223 (2) nm, c = 1.4159 (3) nm, α = 70.38 (1)°, β = 74.91 (1)°, γ = 63.64(1)°, V = 1.7549 (5)° nm~3, Z = 4, D_c = 1.326 g/cm~3, μ = 0.092 mm~(-1), F(000) = 736, R = 0.0436, wR = 0.1076。此化合物通过分子间氢键形成沿α轴无限延伸的一维 链状结构的超分子，由于分子间的作用力使其分子又沿b轴呈层状堆积。     

4-(2'-羟基苯甲酰肼)苯亚甲基／亚乙基－5－甲基－2－苯基－2，4－二氢－吡唑啉酮－3超分子化合物的合成与晶体结构

报道了4-(2'－羟基苯甲酰肼)苯亚甲基－5－甲基－2－苯基－2，4－二氢－吡 唑啉酮－3（B_1）和4-(2'－羟基苯甲酰肼)亚乙基－5－甲基－2－苯基－2，4－二 氢－吡唑啉酮－3（B_2）的合成、表征及晶体结构分析，B_1晶体属单斜晶系， C2/c空间群，所得晶胞参数为：a = 1.4201(2) nm, b = 1.65542(2) nm, c = 1. 8455(3) nm, β = 101.32(1)°，V = 4.2541(10) nm~3, Z = 8, D_c = 1.344 g/cm~3, μ = 0.094 mm~(-1), F(000) = 1808, R = 0.0442, wR = 0.1037。该 化合物由水分子通过氢键连接成沿ac面无限延伸的二维网络结构的超分子。B_2晶 体属三斜晶系，P1空间群，a = 1.2120(2) nm, b = 1.2223 (2) nm, c = 1.4159 (3) nm, α = 70.38 (1)°, β = 74.91 (1)°, γ = 63.64(1)°, V = 1.7549 (5)° nm~3, Z = 4, D_c = 1.326 g/cm~3, μ = 0.092 mm~(-1), F(000) = 736, R = 0.0436, wR = 0.1076。此化合物通过分子间氢键形成沿α轴无限延伸的一维 链状结构的超分子，由于分子间的作用力使其分子又沿b轴呈层状堆积。     

2-乙氨基-6H-5-(1-苯基-3-甲基/苯基-5-吡唑啉酮-4-基)-1,3,4-噻二嗪的合成和晶体结构

利用1-苯基-3-甲基/苯基-4-氯乙酰基-吡唑啉酮-5(PMCP/DPCP)与4-乙基氨基硫脲(ETSC)发生缩合反应,生成了2个新的双杂环化合物2-乙氨基-6H-5-(1-苯基-3-甲基/苯基-5-吡唑啉酮-4-基)-1,3,4-噻二嗪(PMCP-ETSC/DPCP-ETSC),并对其进行元素分析、红外光谱、核磁共振表征和晶体结构分析.PMCP-ETSC晶体属于单斜晶系,Pm空间群,晶胞参数:a=0.7947(1)nm,b=0.8348(1)nm,c=1.1990(2)nm,β=106.07(1)°,V=0.77269(2)nm3,Z=2,Dc=1.356g/cm3,μ=0.219mm-1,F(000)=332,R=0.0298,wR=0.0704.该化合物通过分子间氢键形成沿c轴无限延伸的一维链状结构.DPCP-ETSC晶体属于正交晶系,Pna21空间群,晶胞参数:a=1.1478(2)nm,b=1.3545(2)nm,c=1.1994(2)nm,V=1.8646(4)nm3,Z=4,Dc=1.345g/cm3,μ=0.194mm-1,F(000)=792,R=0.0345,wR=0.0694,此化合物通过分子间氢键形成沿c轴成链状,沿ab平面成波浪状的超分子结构.     

1-苯基-3-甲基-4-(6-氢-4-甲基氨基-5-硫杂-2,3-吡嗪)-吡唑啉酮的合成与晶体结构

通过1-苯基-3-甲基-4-氯乙酰基-吡唑啉酮-5 (PMCP) 和4-甲基氨基硫脲 (MTSC) 缩合, 形成了一种新的双杂环化合物 (PMCP-MTSC)。利用元素分析与单晶X-射线衍射进行了表征。 该化合物(C14H15N5OS)属单斜晶系, P21 空间群, 晶体学参数为 a = 7.634(1), b = 11.639(2), c = 8.150(2) ? ?= 98.13(1), V = 716.9(2) ?, Z = 2, Dc = 1.396 g/cm3, (MoKa) = 0.232 mm-1, F(000) = 316, Mr = 301.37。结构由直接法解出,共收集3114个衍射点,其中I > 2(I)的独立衍射点有2453个,用全矩阵最小二乘法修正,最终偏离因子:R = 0.0294, wR = 0.0738。结构分析表明: 该化合物以酮式存在,分子间通过氢键作用(N(5)H…O)连接起来并形成一维链状结构。     

2－甲基－3－芳基－7－（5，5－二甲基－3－酮－1－环己烯－1－基）甲酸酯－4（3H）－喹唑啉酮的合成

以2－氨基对苯二甲酸（1）为起始原料，与乙酸酐缩合生成7－羧基乙酰苯邻 甲内酰胺（2）；2和芳胺缩合产生7－羧基－2－甲基－3－芳基－4（3H）－喹唑啉 酮（3）；3和N，N－双环己基碳双亚胺（DCC）加成得到中间体4，4在4－二甲氨基 吡啶（DMAP）催化下和5，5－二甲基－1，3－环己二酮（5）缩合得到目标产物2－ 甲基－3－芳基－7－（5，5－二甲基－3－酮－1－环己烯－1－基）甲酸酯－4（ 3H）－喹唑啉酮（6）。所得15个新型化合物的结构均经^1H NMR、元素分析确证， 部分化合物经IC／MSD确证。     

无溶剂微波促进下1－苯基－3－甲基－5－吡唑啉酮与芳酰氯的反应研究

无溶剂条件下，微波促进1－苯基－3－甲基－5－吡唑啉酮与等量的酰氯反应 ，可高产率简便得到5－酰化产物。在有氢氧化钙存在时与2倍量的酰氯反应主要得 到4，5－位酰化产物，产物结构经^1H NMR,^13C NMR,IR,MS及元素分析进行了表征。     

（5－氨基吡唑啉酮－3）－核糖核苷的合成研究

（５－氨基吡唑啉酮－３）－核糖核苷的合成研究沙耀武，蔡孟深（北京医科大学药学院，１０００８３）天然结构类似物的合成是寻找人工药物的有效途径之一。如抗癌药硫代嘌呤。天然核苷的结构类似物都有不同程度的生物活性。如７－去氮腺苷可取代天然腺苷被摄入ＤＮＡ中，...     

1-苯基-3-甲基-4-苯甲酰吡唑啉酮-5萃取镓的研究

首次报道了1-苯基-3-甲基-4-苯甲酰吡唑啉酮-5(HPMBP)萃取镓的热力学和动力学, 指出在体系中形成Ga(PMBP)3(H2O)2萃合物, 配体PMBP既有一次溶剂化作用, 又有二次溶剂化作用, 并得到红外光谱和核磁共振谱的证实。镓的萃取过程为水相化学反应控制, 决速步骤为一次溶剂化过程: Ga^3^++HPMBP→Ga(PMBP)^2^++H^+。添加剂三辛基氧化膦(TOPO)不影响HPMBP萃取镓的分配比, 但降低了HPMBP萃取镓的正向速率, 表明动力学抑萃作用与热力学抑萃作用无对应关系。     

2－芳酰氨基－5－（5－苯基－2H－四唑2－甲基）－1，3，4－噻二唑类化合物的合成

在浓硫酸作用下，由５－（５－苯基－２Ｈ四唑－２－乙酰基）－４－芳酰氨基硫脲１ａ～ｎ制得了一系列新的２－芳酰氨基－５－（５－苯基－２Ｈ－四唑－２－甲基）－１，３，４－噻二唑化合物（２ａ～ｎ）。所有化合物的结构均经元素分析、ＭＳ分析，部分代表化合物经ＩＲ、￣ＨＮＭＲ分析确证；初步观察了２ａ～ｎ在１％浓度下对大肠杆菌（Ｇ￣－）的抑制作用，发现２ｄ，２ｅ，２ｆ，２ｎ显示出较强的活性。     

几种新的4-酰代吡唑啉酮衍生物的合成与结构

利用4-酰代吡唑啉酮与氨基硫脲类化合物反应制备了新的吡唑啉酮类衍生物,并用IR,NMR,MS和元素分析进行表征,最后用X射线四圆衍射对其中的2个化合物进行了晶体结构测定。     

A Theoretical Study on the Photochromic Mechanism of 1-Phenyl-3-methyl-4-（6-hydro-4-amino-5-sulfo-2,3-pyrazine）-pyrazole-5-one

The photochromic mechanism of 1-phenyl-3-methyl-4-（6-hydro-4-amino-5-sulfo-2,3- pyrazine）-pyrazole-5-one has been investigated using the density functional theory（DFT）. The solvent effect is simulated using the polarizable continuum model（PCM） of the self-consistent reaction field theory. According to the crystal structure of the title compound, an intramolecular proton transfer mechanism from enol to keto form was proposed to interpret its photochromism. Bader＇s atom-in-molecule（AIM） theory is used to investigate the nature of hydrogen bonds and ring structures. Time-dependent density functional theory（TDDFT） calculation results show that the photochromic process from enol to keto form is reasonable. The conformation and molecular orbital analysis of enol and keto forms explain why only intramolecular proton transfer is possible. The results from analyzing the energy and dipole moments of enol form, transition state and keto form in the gas phase and in different solvents have been used to assess the stability of the title compound.     

Theoretical study on molecular structures, intramolecular proton transfer reaction, and solvent effects of 1-phenyl-3-methyl-4-(6-hydro-4-amino-5-sulfo-2,3-pyrazine)-pyrazole-5-one

The molecular structures and intramolecular proton transfer reaction of 1-phenyl-3-methyl-4-(6-hydro-4-amino-5-sulfo-2,3-pyrazine)-pyrazole-5-one have been investigated with both ab initio method and the density functional theory. The solvent effects are simulated using the self-consistent reaction field (SCRF) method within the framework of the polarizable continuum model (PCM). The results show that the computed geometrical parameters at the B3LYP levels are in better agreement with experimental values than those at the RHF levels, and the choice of functional in DFT plays an important role in describing the title compound. It is found that strong hydrogen bonds (O–H···N and O···H–N) exist in the title compound, and in the proton transfer process, the O–H bond is broken while the N–H bond is formed. In addition, the order of stability of the isomers remains the same in different solvents, while the barrier height of the proton transfer reaction and dipole moments for the title compound grow with the increase of the solvent polarity. Eventually, the NBO analysis shows that the strength of the hydrogen bond reduces with the increase of the solvent polarity.     

N-(1-苯基-3-甲基-4-苯亚甲基-5-吡唑啉酮)对硝基苯甲酰肼(PMBP-PNH)的合成和晶体结构

合成了标题化合物(C24H19N5O4,Mr = 441.44),晶体属单斜晶系,P21/n空间群,晶胞参数为: a = 9.151(2) , b = 18.405(5) , c = 13.061(3) , = 101.12(1), V = 2158.5(9) 3, Z = 4, Dc = 1.358 g/cm3, = 0.096 mm-1, F(000) = 920, R = 0.0468,wR = 0.1090。分子间以氢键形成二聚体。     

1-苯基-3-甲基-4-(4-羟基-3-甲氧基)-苯甲叉-吡唑啉酮的微波合成和晶体结构

标题化合物C18H16N2O3是由香草醛和1-苯基-3-甲基-吡唑啉酮用微波辐射反应得到,结构通过单晶X-射线衍射法确定,其晶体属单斜晶系,空间群P21/c,Mr = 308.33, a = 21.101(4), b = 7.984, c = 20.076 ? = 115.81(1)? V = 3044.8(8) ? Z = 8, Dc = 1.345 g/cm3, = 0.093 cm-1, F(000) = 1296, 最终的偏离因子为R = 0.0403, wR = 0.0780, 分子之间存在氢键,形成了网状结构。     

Synthesis and Crystal Structure of N-（1-Phenyl-3-methyl-4-benzal-pyrazolone-5）-furoic Hydrazide

1 INTRODUCTION In recent years, investigations on the com- pounds containing hydrazide or hydrazone moieties have been increased considerably because of their potentially biological activities, especially as poten- tial inhibitors for many enzymes[1～5]. The presence of weak molecular interactions such as hydrogen- bonding controls the conformational and structural features which are important to the drug action[6, 7]. We have synthesized the photochromic compounds of pyrazolone thiosemi…     

Synthesis and Crystal Structure of 4-Bromo-5-ethoxy-3-methyl-5- （naphthalen- 1-yl）- 1-tosyl- 1H-pyrrol-2（5H）- one

The title compound 4-bromo-5-ethoxy-3-methyl-5-(naphthalen-1-yl)-1-tosyl-1H- pyrrol-2(5H)-one 1 (C24H22BrNO4S, Mr = 500.40) has been synthesized and its crystal structure was determined by single-crystal X-ray diffraction analysis. It crystallizes in monoclinic, space group P21/n with a = 8.8562(15), b = 18.118(3), c = 14.055(2) , β = 99.855(3)o, V = 2221.9(6) 3, Z = 4, Dc = 1.496 g/cm3, μ = 1.975 mm-1, λ = 0.71073 , F(000) = 1024, R = 0.0607 and wR = 0.1371.     

Crystal Structure of a Novel Compound： 1-Phenyl-3-ethyl-4-（salicylidene hydrazide）-propenylidene-pyrazolone-5

1 INTRODUCTION 4-Acyl pyrazolones and their derivatives, reported to behave as effective chelating and extracting rea- gents for many metal ions, not only play a key role in coordination compounds with wide applications in several fields, from new materials[1] to catalysts[2] as precursors for CVD in the microe-lectronic Indus- try[3] and as potential antitumourals[4], but also are the focus of research as potential antifungal agro- chemicals and widely used as antiviral, antipyretic anal…     

N-苯基-3-(p-氯苯)全氢螺[苯并[b]异■唑7,1′环己烷]-4酮的合成及晶体结构

合成并测定了N-苯基-3－（p-氯苯）全氢螺[苯并[b]异唑7，1-环已烷]-4-酮（3）的单晶结构，晶体分子式C24H26ClNO2,Mr=395.93，晶体属单科晶系，空间群为P21／c，晶胞参数结构的偏离因子R=0．037，Rw=0．039。分子3存在着两个螺六员环（A和B），A环具有通常的椅式构型，B环是扭船式构型。B环和五员异呼吐环C环并连，C环有些扭曲，结构分析结果表明，分子3具有“顺-顺”构型。     

Synthesis and Crystal Structure of 4-（4-Chlorophenyl）-6-methyl-5-methoxy-caronyl-3,4-dihydropyrimidin-2（H）-one

1 INTRODUCTION Biginelli reaction is a three-component condensa-tion of ethyl acetoacetate, benzaldehyde and urea forthe synthesis of 3,4-dihydropyrimidin-2(1H)-ones(Scheme 1). The reaction can be carried out in aone-pot fashion in alcohol solution in t…